👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Trulieve Cannabis CTO Jhala Nilyum buys shares worth $37,670

Published 11/14/2024, 06:09 PM
TRUL
-

Jhala Nilyum, the Chief Technology Officer of Trulieve Cannabis (OTC:TCNNF) Corp. (CSE:TRUL), recently acquired a total of 6,000 subordinate voting shares in a series of transactions. The shares were purchased on three separate occasions between November 8 and November 12, 2024. The purchase prices ranged from $5.70 to $6.98 per share, totaling approximately $37,670.

These transactions were conducted indirectly by Nilyum's spouse. Following these acquisitions, the total number of shares owned by Nilyum stands at 114,778. The purchases reflect a continued investment in Trulieve Cannabis, a company known for its focus on medicinal chemicals and botanical products.

InvestingPro Insights

The recent insider purchases by Trulieve Cannabis Corp.'s CTO, Jhala Nilyum, come at a time when the company's stock has faced significant challenges. According to InvestingPro data, Trulieve's stock price has fallen dramatically over the past year, with a 99.0% decline in the one-year price total return. This downward trend has continued in recent months, with a 99.9% drop in the three-month price total return.

These insider purchases could be seen as a vote of confidence in the company's future prospects, despite the current market sentiment. However, investors should be aware of some potential risks highlighted by InvestingPro Tips. The stock generally trades with high price volatility, which may explain the recent sharp declines. Additionally, Trulieve suffers from weak gross profit margins and does not pay a dividend to shareholders, which could be factors contributing to investor hesitation.

It's worth noting that the company's average daily trading volume over the past three months has been relatively low at 0.07 million USD, which may impact liquidity for investors looking to trade larger positions.

For a more comprehensive analysis, InvestingPro offers additional tips and insights that could be valuable for investors considering Trulieve Cannabis Corp. In fact, there are 8 additional tips available on the InvestingPro platform, providing a deeper understanding of the company's financial health and market position.

Jhala Nilyum, the Chief Technology Officer of Trulieve Cannabis Corp. (CSE:TRUL), recently acquired a total of 6,000 subordinate voting shares in a series of transactions. The shares were purchased on three separate occasions between November 8 and November 12, 2024. The purchase prices ranged from $5.70 to $6.98 per share, totaling approximately $37,670.

These transactions were conducted indirectly by Nilyum's spouse. Following these acquisitions, the total number of shares owned by Nilyum stands at 114,778. The purchases reflect a continued investment in Trulieve Cannabis, a company known for its focus on medicinal chemicals and botanical products.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.